Dear BPS Members,
I am currently researching how the degree of market acceptance of a new
technology may affect biotech firms' new product development efforts.
However, I have been unable to find an established method of measuring the
extent to which external firm stakeholders (e.g., customers, prospective
investors, government regulators) perceive a new technology to be
legitimate or viable. Some closely related research I have reviewed is
contained in the product lifecycle literature, but I was not able to find
any empirical guidelines on how one should go about measuring market
acceptance of a new technology. Any suggestions would be much
appreciated.
Best Regards,
Tony Lewis
University of Wisconsin, Milwaukee
Lubar School of Business - Department of Management